These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 10685120

  • 1. Effect of hormone replacement therapy on the bone mass and urinary excretion of pyridinium cross-links.
    Pardini DP, Sabino AT, Meneses AM, Kasamatsu T, Vieira JG.
    Sao Paulo Med J; 2000 Jan 06; 118(1):3-6. PubMed ID: 10685120
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links.
    Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD.
    J Clin Endocrinol Metab; 1991 Feb 06; 72(2):367-73. PubMed ID: 1991806
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis.
    Toussirot E, Ricard-Blum S, Dumoulin G, Cedoz JP, Wendling D.
    Rheumatology (Oxford); 1999 Jan 06; 38(1):21-7. PubMed ID: 10334678
    [Abstract] [Full Text] [Related]

  • 8. Urinary deoxypyridinoline is a useful biochemical bone marker for the management of postmenopausal osteoporosis.
    Yu SL, Ho LM, Lim BC, Sim ML.
    Ann Acad Med Singap; 1998 Jul 06; 27(4):527-9. PubMed ID: 9791660
    [Abstract] [Full Text] [Related]

  • 9. Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Effects of corticosteroids and hormone replacement therapy.
    Hall GM, Spector TD, Delmas PD.
    Arthritis Rheum; 1995 Jul 06; 38(7):902-6. PubMed ID: 7612039
    [Abstract] [Full Text] [Related]

  • 10. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.
    J Bone Miner Res; 1996 Mar 06; 11(3):337-49. PubMed ID: 8852944
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
    Greenspan SL, Parker RA, Ferguson L, Rosen HN, Maitland-Ramsey L, Karpf DB.
    J Bone Miner Res; 1998 Sep 06; 13(9):1431-8. PubMed ID: 9738515
    [Abstract] [Full Text] [Related]

  • 14. Effects of tamoxifen and toremifene on urinary excretion of pyridinoline and deoxypyridinoline and bone density in postmenopausal patients with breast cancer.
    Marttunen MB, Hietanen P, Titinen A, Roth HJ, Viinikka L, Ylikorkala O.
    Calcif Tissue Int; 1999 Nov 06; 65(5):365-8. PubMed ID: 10541761
    [Abstract] [Full Text] [Related]

  • 15. Serum collagen crosslinks as markers of bone turn-over during GH replacement therapy in growth hormone deficient adults.
    Rodríguez-Arnao J, James I, Jabbar A, Trainer PJ, Perrett D, Besser GM, Ross RJ.
    Clin Endocrinol (Oxf); 1998 Apr 06; 48(4):455-62. PubMed ID: 9640412
    [Abstract] [Full Text] [Related]

  • 16. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL, Loft AG, Møller N, Weeke J, Eriksen EF, Mosekilde L, Charles P.
    J Bone Miner Res; 1997 Jan 06; 12(1):78-88. PubMed ID: 9240729
    [Abstract] [Full Text] [Related]

  • 17. Sublingual administration of micronized estradiol and progesterone, with and without micronized testosterone: effect on biochemical markers of bone metabolism and bone mineral density.
    Miller BE, De Souza MJ, Slade K, Luciano AA.
    Menopause; 2000 Jan 06; 7(5):318-26. PubMed ID: 10993031
    [Abstract] [Full Text] [Related]

  • 18. The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.
    Tascioglu F, Colak O, Armagan O, Alatas O, Oner C.
    Rheumatol Int; 2005 Nov 06; 26(1):21-9. PubMed ID: 15688191
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
    Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ.
    J Bone Miner Res; 2004 Aug 06; 19(8):1221-30. PubMed ID: 15231008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.